Cormedix Inc logo

Cormedix Inc

$ 2.88 -0.07 (-2.37%) 10:08 PM EST
P/E:
At Loss
P/B:
1.92
Market Cap:
$ 118.68M
Enterprise V:
$ 54.92M
Volume:
207.57K
Avg Vol (2M):
495.45K
Also Trade In:
Volume:
207.57K
Market Cap $:
118.68M
PE Ratio:
At Loss
Avg Vol (2-Month):
495.45K
Enterprise Value $:
54.92M
PB Ratio:
1.92
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Cormedix Inc is a biopharmaceutical company that focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has been in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. The Neutrolin product is designed to target unmet medical needs.
Name Current Vs Industry Vs History
Cash-To-Debt 74.79
Equity-to-Asset 0.91
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6
Distress
Grey
Safe
Beneish M-Score -4.9
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 8.43
9-Day RSI 21.44
14-Day RSI 30.87
6-1 Month Momentum % -33.5
12-1 Month Momentum % -17.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 12.4
Quick Ratio 12.4
Cash Ratio 12.26
Days Inventory 126.53
Days Sales Outstanding 70.48
Days Payable 8269.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.5

Financials (Next Earnings Date:2022-11-09 Est.)

CRMD's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CRMD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.123
EPS (TTM) ($) -0.79
Beta 1.89
Volatility % 77.49
14-Day RSI 30.87
14-Day ATR ($) 0.252214
20-Day SMA ($) 3.4345
12-1 Month Momentum % -17.51
52-Week Range ($) 2.645 - 8.025
Shares Outstanding (Mil) 41.21

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cormedix Inc Filings

Document Form Filing Date
No Filing Data

Cormedix Inc Analysis

Share your research

Headlines

See More
No news.